TGFB1 and neoplasm: We speculate that within the tumor microenvironment, tumor cells can trigger activated platelet release granules that contain platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), and transforming growth factor β (TGF-β), which lead to decreased in size and increased heterogeneity of platelet at an early stage of tumor 10.